A study to evaluate the use of eSight magnifying glasses in adults with Low Visio
- Conditions
- D015354blindness in one eye and subnormal vision in the contralateral eyesubnormal vision in both eyes
- Registration Number
- RBR-2vw8282
- Lead Sponsor
- IPEPO - Instituto Paulista de Estudos e PEsquisas em Oftalmologia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
lucid, mentally competent and with stable vision in the last 6 months who can attend the examination site. Best corrected visual acuity in the best eye ranging from 20/60 to 20/400 and / or visual field> 20º (monocular or binocular) with one of the following comorbidities: Stargardt's disease, Eye coloboma, Nystagmus, Aniridia, Retinopathy of Prematurity, Macular degeneration Age-related, Retinal Detachment, Diabetic Retinopathy, Uveitis and other infectious diseases, Cone dystrophy, Leber's Congenital Amaurosis, Pigmentary Retinosis, Optic Nerve Hypopasia, Glaucoma, Optic Nerve Atrophy, Neuropathy. The patient must accept to use eSight in varied situations that simulate everyday situations and in public environments, open and or closed or at the discretion of the investigator.
Visual acuity better corrected in the best eye better than 20/60. Inability to attend the examination site to perform it. Inability to understand the use of the equipment and to provide data to assess its use.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual improvement will be verified after trainning with the optical device, distance visual acuity will be measured by a Snellen chart. Improvemento of vision will be considered when reading 3 or more lines compared the data from pre and pos intervention.
- Secondary Outcome Measures
Name Time Method o secondary outcomes are expected